Ovine serum biomarkers of early and late phase scrapie

BMC Veterinary Research

Volumn 6, Issue , 2010, Pages

  Batxelli Molina, Isabelle ^a   Salvetat, Nicolas ^a   Andréoletti, Olivier ^b   Guerrier, Luc ^c   Vicat, Guillaume ^a   Molina, Franck ^a   Mourton Gilles, Chantal ^a  

^a Cap delta Parc Euromédecine   (France)

^b IHAP   (France)

^c Bio Rad   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; CRICETINAE; MESOCRICETUS AURATUS; OVIS; OVIS ARIES;

BIOLOGICAL MARKER;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; FEMALE; GENE EXPRESSION PROFILING; HAMSTER; MALE; MASS SPECTROMETRY; REPRODUCIBILITY; SCRAPIE; SENSITIVITY AND SPECIFICITY; SHEEP; SYRIAN HAMSTER;

ANIMALS; BIOLOGICAL MARKERS; CRICETINAE; FEMALE; GENE EXPRESSION PROFILING; MALE; MESOCRICETUS; REPRODUCIBILITY OF RESULTS; SCRAPIE; SENSITIVITY AND SPECIFICITY; SHEEP; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 77958567945     PISSN: None     EISSN: 17466148     Source Type: Journal    
DOI: 10.1186/1746-6148-6-49     Document Type: Article

References (66)

1. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998, 95(23):13363-13383. 10.1073/pnas.95.23.13363, 33918, 9811807.
2. Griffith JS. Self-replication and scrapie. Nature 1967, 215(105):1043-1044. 10.1038/2151043a0, 4964084.
3. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982, 216(4542):136-144. 10.1126/science.6801762, 6801762.
4. Belt PB, Muileman IH, Schreuder BE, Bos-de Ruijter J, Gielkens AL, Smits MA. Identification of five allelic variants of the sheep PrP gene and their association with natural scrapie. J Gen Virol 1995, 76(Pt 3):509-517. 10.1099/0022-1317-76-3-509, 7897344.
5. Smits MA, Bossers A, Schreuder BE. Prion protein and scrapie susceptibility. Vet Q 1997, 19(3):101-105.
6. Elsen JM, Amigues Y, Schelcher F, Ducrocq V, Andreoletti O, Eychenne F, Khang JV, Poivey JP, Lantier F, Laplanche JL. Genetic susceptibility and transmission factors in scrapie: detailed analysis of an epidemic in a closed flock of Romanov. Arch Virol 1999, 144(3):431-445. 10.1007/s007050050516, 10226611.
7. Hunter N. Natural transmission and genetic control of susceptibility of sheep to scrapie. Curr Top Microbiol Immunol 1991, 172:165-180.
8. Hunter N, Goldmann W, Foster JD, Cairns D, Smith G. Natural scrapie and PrP genotype: case-control studies in British sheep. Vet Rec 1997, 141(6):137-140. 10.1136/vr.141.6.137, 9280041.
9. Hunter N. PrP genetics in sheep and the applications for scrapie and BSE. Trends Microbiol 1997, 5(8):331-334. 10.1016/S0966-842X(97)01081-0, 9263413.
10. Diaz C, Vitezica ZG, Rupp R, Andreoletti O, Elsen JM. Polygenic variation and transmission factors involved in the resistance/susceptibility to scrapie in a Romanov flock. J Gen Virol 2005, 86(Pt 3):849-857. 10.1099/vir.0.80412-0, 15722548.
11. Groschup MH, Lacroux C, Buschmann A, Luhken G, Mathey J, Eiden M, Lugan S, Hoffmann C, Espinosa JC, Baron T, et al. Classic scrapie in sheep with the ARR/ARR prion genotype in Germany and France. Emerg Infect Dis 2007, 13(8):1201-1207. 2828083, 17953092.
12. Le Dur A, Beringue V, Andreoletti O, Reine F, Lai TL, Baron T, Bratberg B, Vilotte JL, Sarradin P, Benestad SL, et al. A newly identified type of scrapie agent can naturally infect sheep with resistant PrP genotypes. Proc Natl Acad Sci USA 2005, 102(44):16031-16036. 10.1073/pnas.0502296102, 1276041, 16239348.
13. Jeffrey M, Gonzalez L. Classical sheep transmissible spongiform encephalopathies: pathogenesis, pathological phenotypes and clinical disease. Neuropathol Appl Neurobiol 2007, 33(4):373-394. 10.1111/j.1365-2990.2007.00868.x, 17617870.
14. Andreoletti O, Berthon P, Marc D, Sarradin P, Grosclaude J, van Keulen L, Schelcher F, Elsen JM, Lantier F. Early accumulation of PrP(Sc) in gut-associated lymphoid and nervous tissues of susceptible sheep from a Romanov flock with natural scrapie. J Gen Virol 2000, 81(Pt 12):3115-3126.
15. Aguzzi A. Peripheral prion pursuit. J Clin Invest 2001, 108(5):661-662. 209391, 11544269.
16. Schreuder BE, van Keulen LJ, Vromans ME, Langeveld JP, Smits MA. Tonsillar biopsy and PrPSc detection in the preclinical diagnosis of scrapie. Vet Rec 1998, 142(21):564-568. 10.1136/vr.142.21.564, 9634704.
17. O'Rourke KI, Baszler TV, Besser TE, Miller JM, Cutlip RC, Wells GA, Ryder SJ, Parish SM, Hamir AN, Cockett NE, et al. Preclinical diagnosis of scrapie by immunohistochemistry of third eyelid lymphoid tissue. J Clin Microbiol 2000, 38(9):3254-3259. 87369, 10970367.
18. Monleon E, Monzon M, Hortells P, Bolea R, Acin C, Vargas F, Badiola JJ. Approaches to Scrapie diagnosis by applying immunohistochemistry and rapid tests on central nervous and lymphoreticular systems. J Virol Methods 2005, 125(2):165-171. 10.1016/j.jviromet.2005.01.013, 15794986.
19. Espenes A, Press CM, Landsverk T, Tranulis MA, Aleksandersen M, Gunnes G, Benestad SL, Fuglestveit R, Ulvund MJ. Detection of PrP(Sc) in Rectal Biopsy and Necropsy Samples from Sheep with Experimental Scrapie. J Comp Pathol 2006, 134(2):115-125. 10.1016/j.jcpa.2005.08.001, 16466737.
20. Langeveld JP, Jacobs JG, Erkens JH, Bossers A, van Zijderveld FG, van Keulen LJ. Rapid and discriminatory diagnosis of scrapie and BSE in retro-pharyngeal lymph nodes of sheep. BMC Vet Res 2006, 2(1):19. 10.1186/1746-6148-2-19, 1544330, 16764717.
21. Monleon E, Garza MA, Sarasa R, Alvarez-Rodriguez J, Bolea R, Monzon M, Vargas MA, Badiola JJ, Acin C. An assessment of the efficiency of PrPsc detection in rectal mucosa and third-eyelid biopsies from animals infected with scrapie. Vet Microbiol
22. Hunter N, Foster J, Chong A, McCutcheon S, Parnham D, Eaton S, MacKenzie C, Houston F. Transmission of prion diseases by blood transfusion. J Gen Virol 2002, 83(Pt 11):2897-2905.
23. Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 1996, 335(13):924-930. 10.1056/NEJM199609263351303, 8782499.
24. Zerr I, Bodemer M, Racker S, Grosche S, Poser S, Kretzschmar HA, Weber T. Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease. Lancet 1995, 345(8965):1609-1610. 10.1016/S0140-6736(95)90118-3, 7783539.
25. Aksamit AJ, Preissner CM, Homburger HA. Quantitation of 14-3-3 and neuron-specific enolase proteins in CSF in Creutzfeldt-Jakob disease. Neurology 2001, 57(4):728-730.
26. Otto M, Stein H, Szudra A, Zerr I, Bodemer M, Gefeller O, Poser S, Kretzschmar HA, Mader M, Weber T. S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J Neurol 1997, 244(9):566-570. 10.1007/s004150050145, 9352454.
27. Beaudry P, Cohen P, Brandel JP, Delasnerie-Laupretre N, Richard S, Launay JM, Laplanche JL. 14-3-3 protein, neuron-specific enolase, and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Dement Geriatr Cogn Disord 1999, 10(1):40-46. 10.1159/000017095, 10068257.
28. Otto M, Wiltfang J, Tumani H, Zerr I, Lantsch M, Kornhuber J, Weber T, Kretzschmar HA, Poser S. Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurosci Lett 1997, 225(3):210-212. 10.1016/S0304-3940(97)00215-2, 9147407.
29. Itoh N, Arai H, Urakami K, Ishiguro K, Ohno H, Hampel H, Buerger K, Wiltfang J, Otto M, Kretzschmar H, et al. Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease. Ann Neurol 2001, 50(2):150-156. 10.1002/ana.1054, 11506396.
30. Otto M, Wiltfang J, Cepek L, Neumann M, Mollenhauer B, Steinacker P, Ciesielczyk B, Schulz-Schaeffer W, Kretzschmar HA, Poser S. Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 2002, 58(2):192-197.
31. Van Everbroeck B, Green AJ, Vanmechelen E, Vanderstichele H, Pals P, Sanchez-Valle R, Corrales NC, Martin JJ, Cras P. Phosphorylated tau in cerebrospinal fluid as a marker for Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2002, 73(1):79-81. 10.1136/jnnp.73.1.79, 1757299, 12082054.
32. Hochstrasser DF, Frutiger S, Wilkins MR, Hughes G, Sanchez JC. Elevation of apolipoprotein E in the CSF of cattle affected by BSE. FEBS Lett 1997, 416(2):161-163. 10.1016/S0014-5793(97)01191-5, 9369204.
33. Volkel D, Zimmermann K, Zerr I, Lindner T, Bodemer M, Poser S, Schwarz HP. C-reactive protein and IL-6: new marker proteins for the diagnosis of CJD in plasma?. Transfusion 2001, 41(12):1509-1514. 10.1046/j.1537-2995.2001.41121509.x, 11778065.
34. Sanchez JC, Guillaume E, Lescuyer P, Allard L, Carrette O, Scherl A, Burgess J, Corthals GL, Burkhard PR, Hochstrasser DF. Cystatin C as a potential cerebrospinal fluid marker for the diagnosis of Creutzfeldt-Jakob disease. Proteomics 2004, 4(8):2229-2233. 10.1002/pmic.200300799, 15274116.
35. Sjogren M. EDRF transcripts and diagnosis of variant Creutzfeldt-Jakob disease. Lancet 2001, 357(9274):2069-2070. 10.1016/S0140-6736(00)05224-7, 11445093.
36. Miele G, Manson J, Clinton M. A novel erythroid-specific marker of transmissible spongiform encephalopathies. Nat Med 2001, 7(3):361-364. 10.1038/85515, 11231637.
37. Aguzzi A. Understanding the diversity of prions. Nat Cell Biol 2004, 6(4):290-292. 10.1038/ncb0404-290, 15057242.
38. Aguzzi A. Neuro-immune connection in spread of prions in the body?. Lancet 1997, 349(9054):742-743. 10.1016/S0140-6736(97)22011-8, 9074567.
39. Castilla J, Saa P, Soto C. Detection of prions in blood. Nat Med 2005, 11(9):982-985.
40. Castilla J, Saa P, Morales R, Abid K, Maundrell K, Soto C. Protein misfolding cyclic amplification for diagnosis and prion propagation studies. Methods Enzymol 2006, 412:3-21. 10.1016/S0076-6879(06)12001-7, 17046648.
41. An SS, Lim KT, Oh HJ, Lee BS, Zukic E, Ju YR, Yokoyama T, Kim SY, Welker E. Differentiating scrapie-infected blood by detecting disease-associated prion proteins by Multimer Detection System. Biochem Biophys Res Commun 2010, 392(4):505-509. 10.1016/j.bbrc.2010.01.053, 20085753.
42. Terry LA, Howells L, Hawthorn J, Edwards JC, Moore SJ, Bellworthy SJ, Simmons H, Lizano S, Estey L, Leathers V, et al. Detection of PrPsc in blood from sheep infected with the scrapie and bovine spongiform encephalopathy agents. J Virol 2009, 83(23):12552-12558. 10.1128/JVI.00311-09, 2786716, 19740979.
43. Lacroux C, Simon S, Benestad SL, Maillet S, Mathey J, Lugan S, Corbiere F, Cassard H, Costes P, Bergonier D, et al. Prions in milk from ewes incubating natural scrapie. PLoS Pathog 2008, 4(12):e1000238. 10.1371/journal.ppat.1000238, 2587713, 19079578.
44. Clarke CH, Buckley JA, Fung ET. SELDI-TOF-MS proteomics of breast cancer. Clin Chem Lab Med 2005, 43(12):1314-1320. 10.1515/CCLM.2005.225, 16309366.
45. Ardekani AM, Liotta LA, Petricoin EF. Clinical potential of proteomics in the diagnosis of ovarian cancer. Expert Rev Mol Diagn 2002, 2(4):312-320. 10.1586/14737159.2.4.312, 12138495.
46. Abdul-Salam VB, Paul GA, Ali JO, Gibbs SR, Rahman D, Taylor GW, Wilkins MR, Edwards RJ. Identification of plasma protein biomarkers associated with idiopathic pulmonary arterial hypertension. Proteomics 2006, 6(7):2286-2294. 10.1002/pmic.200500510, 16493708.
47. Meade-White KD, Barbian KD, Race B, Favara C, Gardner D, Taubner L, Porcella S, Race R. Characteristics of 263 K scrapie agent in multiple hamster species. Emerg Infect Dis 2009, 15(2):207-215. 10.3201/eid1502.081173, 2657641, 19193264.
48. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001, 98(9):5116-5121. 10.1073/pnas.091062498, 33173, 11309499.
49. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993, 39(4):561-577.
50. Kramar A, Faraggi D, Fortune A, Reiser B. mROC: a computer program for combining tumour markers in predicting disease states. Comput Methods Programs Biomed 2001, 66(2-3):199-207. 10.1016/S0169-2607(00)00129-2, 11551393.
51. Y F. Experiments with a New Boosting Algorithm. International Conference on Machine Learning: 1996 1996,
52. Vapnik V, Chapelle O. Bounds on error expectation for support vector machines. Neural Comput 2000, 12(9):2013-2036. 10.1162/089976600300015042, 10976137.
53. Vapnik VN. An overview of statistical learning theory. IEEE Trans Neural Netw 1999, 10(5):988-999. 10.1109/72.788640, 18252602.
54. Box GEP, Cox DR. An analysis of transformations. JRSS B 1964, 26:211-246.
55. Dessau RB, Pipper CB. [''R"--project for statistical computing]. Ugeskr Laeger 2008, 170(5):328-330.
56. Proteomic database. , http://www.expasy.org
57. Hybelova M, Svatonova J, Sobek O, Adam P, Dolezil D, Adam D. Cerebrospinal fluid and serum prealbumin (transthyretin) in patients with multiple sclerosis (MS): comparison of particular subgroups of MS patients. Folia Microbiol (Praha) 2009, 54(2):173-176. 10.1007/s12223-009-0027-4, 19418258.
58. Dardiotis E, Koutsou P, Papanicolaou EZ, Vonta I, Kladi A, Vassilopoulos D, Hadjigeorgiou G, Christodoulou K, Kyriakides T. Epidemiological, clinical and genetic study of familial amyloidotic polyneuropathy in Cyprus. Amyloid 2009, 16(1):32-37. 10.1080/13506120802676948, 19291512.
59. Li YF, Ng H, Sun IU, Leong W. Clinical and genetic analysis of three families with familiar amyloid polyneuropathy. Chin Med Sci J 2008, 23(4):230-233. 10.1016/S1001-9294(09)60044-4, 19180884.
60. Ueda M, Misumi Y, Mizuguchi M, Nakamura M, Yamashita T, Sekijima Y, Ota K, Shinriki S, Jono H, Ikeda S, et al. SELDI-TOF mass spectrometry evaluation of variant transthyretins for diagnosis and pathogenesis of familial amyloidotic polyneuropathy. Clin Chem 2009, 55(6):1223-1227. 10.1373/clinchem.2008.118505, 19372189.
61. Gloeckner SF, Meyne F, Wagner F, Heinemann U, Krasnianski A, Meissner B, Zerr I. Quantitative analysis of transthyretin, tau and amyloid-beta in patients with dementia. J Alzheimers Dis 2008, 14(1):17-25.
62. Golanska E, Gresner S, Sieruta M, Liberski P. [Cerebrospinal fluid markers of prion diseases]. Neurol Neurochir Pol 2008, 42(5):441-450.
63. Vicente H, Outeiro TF. The sour side of neurodegenerative disorders: the effects of protein glycation. J Pathol 2010, 221(1):13-25.
64. Apweiler R, Aslanidis C, Deufel T, Gerstner A, Hansen J, Hochstrasser D, Kellner R, Kubicek M, Lottspeich F, Maser E, et al. Approaching clinical proteomics: current state and future fields of application in fluid proteomics. Clin Chem Lab Med 2009, 47(6):724-744. 10.1515/CCLM.2009.167, 19527139.
65. Barr JB, Watson M, Head MW, Ironside JW, Harris N, Hogarth C, Fraser JR, Barron R. Differential protein profiling as a potential multi-marker approach for TSE diagnosis. BMC Infect Dis 2009, 9:188. 10.1186/1471-2334-9-188, 2794872, 19943924.
66. Johnson CJ, Pedersen JA, Chappell RJ, McKenzie D, Aiken JM. Oral Transmissibility of Prion Disease Is Enhanced by Binding to Soil Particles. PLoS Pathog 2007, 3(7):e93. 10.1371/journal.ppat.0030093, 1904474, 17616973.